KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Depreciation & Amortization (CF) (2016 - 2025)

Biogen has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $200.2 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $200.2 million for Q4 2025, up 8.8% from a year ago — trailing twelve months through Dec 2025 was $779.9 million (up 15.85% YoY), and the annual figure for FY2025 was $779.9 million, up 15.85%.
  • Depreciation & Amortization (CF) for Q4 2025 was $200.2 million at Biogen, down from $202.2 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for BIIB hit a ceiling of $202.2 million in Q3 2025 and a floor of $102.6 million in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $137.4 million (2022), compared with a mean of $147.7 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): decreased 21.52% in 2023 and later surged 46.24% in 2024.
  • Biogen's Depreciation & Amortization (CF) stood at $134.7 million in 2021, then dropped by 11.06% to $119.8 million in 2022, then grew by 16.94% to $140.1 million in 2023, then skyrocketed by 31.33% to $184.0 million in 2024, then rose by 8.8% to $200.2 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $200.2 million (Q4 2025), $202.2 million (Q3 2025), and $194.3 million (Q2 2025) per Business Quant data.